43 related articles for article (PubMed ID: 14673956)
1. Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.
Velazquez EF; Yancovitz M; Pavlick A; Berman R; Shapiro R; Bogunovic D; O'Neill D; Yu YL; Spira J; Christos PJ; Zhou XK; Mazumdar M; Nanus DM; Liebes L; Bhardwaj N; Polsky D; Osman I
J Transl Med; 2007 Jan; 5():2. PubMed ID: 17207277
[TBL] [Abstract][Full Text] [Related]
2. The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells.
Zarei Shandiz S; Assaran Darban R; Javid H; Ghahremanloo A; Hashemy SI
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38334824
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of Neprilysin Is Associated with Inflammation in Preeclampsia.
Atta S; Mekky R; Ibrahim M; Abdallah MM; Elbaz MAH; Radwan E
Reprod Sci; 2024 May; 31(5):1385-1390. PubMed ID: 38114865
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
Butler W; Xu L; Zhou Y; Cheng Q; Hauck JS; He Y; Marek R; Hartman Z; Cheng L; Yang Q; Wang ME; Chen M; Zhang H; Armstrong AJ; Huang J
J Pathol; 2023 May; 260(1):43-55. PubMed ID: 36752189
[TBL] [Abstract][Full Text] [Related]
5. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1β and Cancer.
Rébé C; Ghiringhelli F
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635472
[TBL] [Abstract][Full Text] [Related]
7. Maternal Overweight Downregulates MME (Neprilysin) in Feto-Placental Endothelial Cells and in Cord Blood.
Weiß E; Berger HM; Brandl WT; Strutz J; Hirschmugl B; Simovic V; Tam-Ammersdorfer C; Cvitic S; Hiden U
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012940
[TBL] [Abstract][Full Text] [Related]
8. IL-1-conferred gene expression pattern in ERα
Nawas AF; Kanchwala M; Thomas-Jardin SE; Dahl H; Daescu K; Bautista M; Anunobi V; Wong A; Meade R; Mistry R; Ghatwai N; Bayerl F; Xing C; Delk NA
BMC Cancer; 2020 Jan; 20(1):46. PubMed ID: 31959131
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms.
Huang YH; Zhang YQ; Huang JT
Asian J Androl; 2019; 21(3):291-295. PubMed ID: 30924452
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.
Chatalic KL; Konijnenberg M; Nonnekens J; de Blois E; Hoeben S; de Ridder C; Brunel L; Fehrentz JA; Martinez J; van Gent DC; Nock BA; Maina T; van Weerden WM; de Jong M
Theranostics; 2016; 6(1):104-17. PubMed ID: 26722377
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?
Grigore AD; Ben-Jacob E; Farach-Carson MC
Front Oncol; 2015; 5():37. PubMed ID: 25785244
[TBL] [Abstract][Full Text] [Related]
12. IL-1β induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells.
Chang MA; Patel V; Gwede M; Morgado M; Tomasevich K; Fong EL; Farach-Carson MC; Delk NA
J Cell Biochem; 2014 Dec; 115(12):2188-97. PubMed ID: 25103771
[TBL] [Abstract][Full Text] [Related]
13. Cytokine effects on cell viability and death of prostate carcinoma cells.
Chondrogiannis G; Kastamoulas M; Kanavaros P; Vartholomatos G; Bai M; Baltogiannis D; Sofikitis N; Arvanitis D; Galani V
Biomed Res Int; 2014; 2014():536049. PubMed ID: 24982891
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.
Fournier P; Dumulon-Perreault V; Ait-Mohand S; Langlois R; Bénard F; Lecomte R; Guérin B
EJNMMI Res; 2012 Feb; 2():8. PubMed ID: 22333272
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in prostate cancer.
Sun Y; Niu J; Huang J
Am J Transl Res; 2009 Feb; 1(2):148-62. PubMed ID: 19956427
[TBL] [Abstract][Full Text] [Related]
16. Gene network and canonical pathway analysis in prostate cancer: a microarray study.
Savli H; Szendröi A; Romics I; Nagy B
Exp Mol Med; 2008 Apr; 40(2):176-85. PubMed ID: 18446056
[TBL] [Abstract][Full Text] [Related]
17. Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability.
Gunia S; Albrecht K; Koch S; Herrmann T; Ecke T; Loy V; Linke J; Siegsmund M; May M
World J Urol; 2008 Jun; 26(3):243-50. PubMed ID: 18392627
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation.
Albrecht M; Doroszewicz J; Gillen S; Gomes I; Wilhelm B; Stief T; Aumüller G
Prostate; 2004 Jan; 58(1):82-94. PubMed ID: 14673956
[TBL] [Abstract][Full Text] [Related]
19. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
